Amyrin attenuates scopolamine-induced cognitive impairment in mice

Biological and Pharmaceutical Bulletin

Volumn 37, Issue 7, 2014, Pages 1207-1213

  Park, Se Jin ^a   Ahn, Young Je ^a   Oh, Sa Rang ^c   Lee, Younghwan ^a   Kwon, Guyoung ^a   Woo, Hyun ^a   Lee, Hyung Eun ^a   Jang, Dae Sik ^a   Jung, Ji Wook ^b   Ryu, Jong Hoon ^a  

^a Kyung Hee University   (South Korea)

^b Daegu Haany University   (South Korea)

^c Keimyung University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ACETYLCHOLINESTERASE; ALPHA AMYRIN; BETA AMYRIN; DONEPEZIL; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SCOPOLAMINE; AMYRIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; MUSCARINIC RECEPTOR BLOCKING AGENT; OLEANOLIC ACID; SCOPOLAMINE BROMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; HIPPOCAMPUS; IN VITRO STUDY; LEARNING; MALE; MEMORY DISORDER; MENTAL CAPACITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SINGLE DRUG DOSE; ANALOGS AND DERIVATIVES; ANIMAL; ANIMAL BEHAVIOR; AVOIDANCE BEHAVIOR; CHEMICALLY INDUCED; CHEMISTRY; COGNITION DISORDERS; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; ENZYMOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; MEMORY; METABOLISM; PSYCHOLOGY; SIGNAL TRANSDUCTION;

ACETYLCHOLINESTERASE; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; MALE; MAP KINASE SIGNALING SYSTEM; MEMORY; MICE, INBRED ICR; MUSCARINIC ANTAGONISTS; OLEANOLIC ACID; SCOPOLAMINE HYDROBROMIDE;

EID: 84904601295     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b14-00113     Document Type: Article

References (33)

1. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet, 377, 1019-1031 (2011).
2. Terry AV Jr, Buccafusco JJ. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J. Pharmacol. Exp. Ther., 306, 821-827 (2003).
3. Parsons CG, Danysz W, Dekundy A, Pulte I. Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer's disease. Neurotox. Res., 24, 358-369 (2013).
4. Tayeb HO, Yang HD, Price BH, Tarazi FI. Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors. Pharmacol. Ther., 134, 8-25 (2012).
5. Kim HG, Oh MS. Herbal medicines for the prevention and treatment of Alzheimer's disease. Curr. Pharm. Des., 18, 57-75 (2012).
6. Oh SR, Kim SJ, Kim DH, Ryu JH, Ahn EM, Jung JW. Angelica keiskei ameliorates scopolamine-induced memory impairments in mice. Biol. Pharm. Bull., 36, 82-88 (2013).
7. Lima-Júnior RC, Sousa DI, Brito GA, Cunha GM, Chaves MH, Rao VS, Santos FA. Modulation of acute visceral nociception and bladder inflammation by plant triterpene, α, β- amyrin in a mouse model of cystitis: role of tachykinin NK(1)-receptors, and K(+) (ATP) channels. Inflamm. Res., 56, 487-494 (2007).
8. Matos I, Bento AF, Marcon R, Claudino RF, Calixto JB. Preventive and therapeutic oral administration of the pentacyclic triterpene α, β- amyrin ameliorates dextran sulfate sodium-induced colitis in mice: the relevance of cannabinoid system. Mol. Immunol., 54, 482-492 (2013).
9. Melo CM, Morais TC, Tome AR, Brito GA, Chaves MH, Rao VS, Santos FA. Anti-inflammatory effect of α, β- amyrin, a triterpene from Protium heptaphyllum, on cerulein-induced acute pancreatitis in mice. Inflamm. Res., 60, 673-681 (2011).
10. Simão da Silva KAB, Paszcuk AF, Passos GF, Silva ES, Bento AF, Meotti FC, Calixto JB. Activation of cannabinoid receptors by the pentacyclic triterpene α, β-amyrin inhibits inflammatory and neuropathic persistent pain in mice. Pain, 152, 1872-1887 (2011).
11. Otuki MF, Ferreira J, Lima FV, Meyre-Silva C, Malheiros A, Muller LA, Cani GS, Santos AR, Yunes RA, Calixto JB. Antinociceptive properties of mixture of α- amyrin and β-amyrin triterpenes: evidence for participation of protein kinase C and protein kinase A pathways. J. Pharmacol. Exp. Ther., 313, 310-318 (2005).
12. Aragão GF, Carneiro LM, Junior AP, Vieira LC, Bandeira PN, Lemos TL, Viana GS. A possible mechanism for anxiolytic and antidepressant effects of α- and β-amyrin from Protium heptaphyllum (AUBL.) March. Pharmacol. Biochem. Behav., 85, 827-834 (2006).
13. Lee HE, Lee SY, Kim JS, Park SJ, Kim JM, Lee YW, Jung JM, Kim DH, Shin BY, Jang DS, Kang SS, Ryu JH. Ethanolic extract of the seed of Zizyphus jujuba var. spinosa ameliorates cognitive impairment induced by cholinergic blockade in mice. Biomol. Ther. (Seoul), 21, 299-306 (2013).
14. Riekkinen P Jr. 5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior. Eur. J. Pharmacol., 262, 77-90 (1994).
15. Kim DH, Kim S, Jeon SJ, Son KH, Lee S, Yoon BH, Cheong JH, Ko KH, Ryu JH. Tanshinone I enhances learning and memory, and ameliorates memory impairment in mice via the extracellular signal-regulated kinase signalling pathway. Br. J. Pharmacol., 158, 1131-1142 (2009).
16. Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol., 7, 88-95 (1961).
17. Buchanan KA, Petrovic MM, Chamberlain SE, Marrion NV, Mellor JR. Facilitation of long-term potentiation by muscarinic M(1) receptors is mediated by inhibition of SK channels. Neuron, 68, 948-963 (2010).
18. Soares JC, Oliveira MG, Ferreira TL. Inactivation of muscarinic receptors impairs place and response learning: implications for multiple memory systems. Neuropharmacology, 73, 320-326 (2013).
19. Bartus RT, Dean RL 3rd, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science, 217, 408-414 (1982).
20. Ebert U, Kirch W. Scopolamine model of dementia: electroencephalogram findings and cognitive performance. Eur. J. Clin. Invest., 28, 944-949 (1998).
21. Buccafusco JJ, Terry AV Jr, Webster SJ, Martin D, Hohnadel EJ, Bouchard KA, Warner SE. The scopolamine-reversal paradigm in rats and monkeys: the importance of computer-assisted operantconditioning memory tasks for screening drug candidates. Psychopharmacology (Berl.), 199, 481-494 (2008).
22. Uchida S, Endo S, Akita K, Ohta T, Fukuda S. The cyanine Dye NK-4 improves scopolamine-induced memory impairments in mice. Biol. Pharm. Bull., 35, 1831-1835 (2012).
23. Joh EH, Lee IA, Kim DH. Kalopanaxsaponins A and B isolated from Kalopanax pictus ameliorate memory deficits in mice. Phytother. Res., 26, 546-551 (2012).
24. Giovannini MG. The role of the extracellular signal-regulated kinase pathway in memory encoding. Rev. Neurosci., 17, 619-634 (2006).
25. Atkins CM, Selcher JC, Petraitis JJ, Trzaskos JM, Sweatt JD. The MAPK cascade is required for mammalian associative learning. Nat. Neurosci., 1, 602-609 (1998).
26. Bonner TI, Buckley NJ, Young AC, Brann MR. Identification of a family of muscarinic acetylcholine receptor genes. Science, 237, 527-532 (1987).
27. Felder CC. Muscarinic acetylcholine receptors: signal transduction through multiple effectors. FASEB J., 9, 619-625 (1995).
28. Rosenblum K, Futter M, Jones M, Hulme EC, Bliss TV. ERKI/II regulation by the muscarinic acetylcholine receptors in neurons. J. Neurosci., 20, 977-985 (2000).
29. Peineau S, Taghibiglou C, Bradley C, Wong TP, Liu L, Lu J, Lo E, Wu D, Saule E, Bouschet T, Matthews P, Isaac JT, Bortolotto ZA, Wang YT, Collingridge GL. LTP inhibits LTD in the hippocampus via regulation of GSK3β. Neuron, 53, 703-717 (2007).
30. Wu YY, Wang X, Tan L, Liu D, Liu XH, Wang Q, Wang JZ, Zhu LQ. Lithium attenuates scopolamine-induced memory deficits with inhibition of GSK-3β and preservation of postsynaptic components. J. Alzheimer's Dis., 37, 515-527 (2013).
31. Cai Z, Zhao Y, Zhao B. Roles of glycogen synthase kinase 3 in Alzheimer's disease. Curr. Alzheimer Res., 9, 864-879 (2012).
32. Medina M, Wandosell F. Deconstructing GSK-3: The fine regulation of its activity. Int. J. Alzheimer's Dis., 2011, 479249 (2011).
33. Frödin M, Gammeltoft S. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol. Cell. Endocrinol., 151, 65-77 (1999).